ReP USP - Resultado da busca

Artigo de periodico
Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? (2021)
Wendel, Silvano ; Fachini, Roberta ; Wendel, Rita C. L. Fontão; Santos, Ralyria Mello Vieira dos ; Velasquez, Carlos Vinícius; Machado, Rafael Rahal Guaragna ; Brito, Mayra Altobelli; Amaral, Marcelo; Soares, Camila Pereira ; Achkar, Ruth; Scuracchio, Patrícia ; Miyaji, Sandra Cristina; Erdens, Melina Santos; Durigon, Edison Luiz
Source: Transfusion. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIVIRAIS, COVID-19, DOADORES DE SANGUE, TESTES SOROLÓGICOS, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?. Transfusion, v. 61, n. 12, p. 3455-3467, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16714. Acesso em: 09 maio 2024.
APA
Wendel, S., Fachini, R., Wendel, R. C. L. F., Santos, R. M. V. dos, Velasquez, C. V., Machado, R. R. G., et al. (2021). Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? Transfusion, 61( 12), 3455-3467. doi:10.1111/trf.16714
NLM
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 maio 09 ] Available from: https://doi.org/10.1111/trf.16714
Vancouver
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 maio 09 ] Available from: https://doi.org/10.1111/trf.16714
Artigo de periodico
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections (2021)
Wendel, Silvano ; Wendel, Rita Fontão; Fachini, Roberta; Candelaria, Gabriela ; Scuracchio, Patricia; Achkar, Ruth; Brito, Mayra; Reis, Luiz Fernando ; Camargo, Anamaria ; Amano, Mariane ; Machado, Rafael Rahal Guaragna ; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Durigon, Edison Luiz
Source: Transfusion. Unidade: ICB
Subjects: MICROBIOLOGIA, SANGUE, PLASMA, COVID-19, ESTUDOS LONGITUDINAIS, CINÉTICA QUÍMICA, ANTICORPOS, REAÇÃO EM CADEIA POR POLIMERASE, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, p. 14 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16323. Acesso em: 09 maio 2024.
APA
Wendel, S., Wendel, R. F., Fachini, R., Candelaria, G., Scuracchio, P., Achkar, R., et al. (2021). A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, 14 . doi:10.1111/trf.16323
NLM
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2024 maio 09 ] Available from: https://doi.org/10.1111/trf.16323
Vancouver
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2024 maio 09 ] Available from: https://doi.org/10.1111/trf.16323
Artigo de periodico
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program (2020)
Wendel, Silvano ; Kutner, José Mauro ; Machado, Rafael Rahal Guaragna ; Wendel, Rita Fontão; Bub, Carolina ; Fachini, Roberta; Yokoyama, Ana ; Candelaria, Gabriela ; Sakashita, Araci ; Achkar, Ruth; Hamerschlak, Nelson ; Scuracchio, Patricia; Amaral, Marcelo; Ben, Mirian Dal; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Camargo, Anamaria ; Kallás, Esper Georges ; Durigon, Edison Luiz ; Reis, Luiz Fernando ; Rizzo, Luiz Vicente
Source: Transfusion. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, IMUNOTERAPIA, PLASMA, ANTICORPOS, TRIAGEM, REAÇÃO EM CADEIA POR POLIMERASE, ADJUVANTES IMUNOLÓGICOS, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, p. 1-4, 2020Tradução . . Disponível em: https://doi.org/10.1111/trf.16065. Acesso em: 09 maio 2024.
APA
Wendel, S., Kutner, J. M., Machado, R. R. G., Wendel, R. F., Bub, C., Fachini, R., et al. (2020). Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, 1-4. doi:10.1111/trf.16065
NLM
Wendel S, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.[citado 2024 maio 09 ] Available from: https://doi.org/10.1111/trf.16065
Vancouver
Wendel S, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.[citado 2024 maio 09 ] Available from: https://doi.org/10.1111/trf.16065

USP Schools

ReP

Filtros

Authors

Subjects

Non normalized affiliation